A detailed history of Kcs Wealth Advisory transactions in Merck & Co., Inc. stock. As of the latest transaction made, Kcs Wealth Advisory holds 12,644 shares of MRK stock, worth $1.39 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
12,644
Previous 13,974 9.52%
Holding current value
$1.39 Million
Previous $1.61 Million 19.29%
% of portfolio
0.58%
Previous 0.59%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023

SELL
$102.95 - $114.33 $136,923 - $152,058
-1,330 Reduced 9.52%
12,644 $1.3 Million
Q2 2023

Jul 17, 2023

BUY
$108.61 - $118.38 $34,103 - $37,171
314 Added 2.3%
13,974 $1.61 Million
Q1 2023

Apr 17, 2023

SELL
$102.94 - $114.86 $20,896 - $23,316
-203 Reduced 1.46%
13,660 $1.45 Million
Q4 2022

Feb 07, 2023

BUY
$87.44 - $112.11 $1,836 - $2,354
21 Added 0.15%
13,863 $1.54 Million
Q3 2022

Oct 21, 2022

SELL
$84.53 - $94.96 $120,962 - $135,887
-1,431 Reduced 9.37%
13,842 $1.19 Million
Q2 2022

Jul 22, 2022

BUY
$83.49 - $94.64 $24,212 - $27,445
290 Added 1.94%
15,273 $1.39 Million
Q1 2022

Apr 13, 2022

BUY
$73.51 - $82.4 $57,925 - $64,931
788 Added 5.55%
14,983 $1.23 Million
Q4 2021

Jan 26, 2022

SELL
$72.28 - $90.54 $7,589 - $9,506
-105 Reduced 0.73%
14,195 $1.09 Million
Q3 2021

Oct 20, 2021

BUY
$71.68 - $78.83 $55,695 - $61,250
777 Added 5.75%
14,300 $1.07 Million
Q2 2021

Jul 27, 2021

BUY
$70.31 - $77.77 $54,771 - $60,582
779 Added 6.11%
13,523 $1.05 Million
Q1 2021

Apr 19, 2021

BUY
$68.86 - $81.11 $57,016 - $67,159
828 Added 6.95%
12,744 $982,000
Q4 2020

Jan 28, 2021

BUY
$71.77 - $79.65 $9,617 - $10,673
134 Added 1.14%
11,916 $975,000
Q3 2020

Oct 27, 2020

SELL
$73.18 - $82.95 $36,370 - $41,226
-497 Reduced 4.05%
11,782 $977,000
Q2 2020

Jul 16, 2020

BUY
$70.42 - $80.13 $4,295 - $4,887
61 Added 0.5%
12,279 $950,000
Q1 2020

Apr 28, 2020

BUY
$63.36 - $87.82 $14,636 - $20,286
231 Added 1.93%
12,218 $940,000
Q4 2019

Jan 15, 2020

SELL
$77.58 - $87.54 $11,869 - $13,393
-153 Reduced 1.26%
11,987 $1.09 Million
Q3 2019

Oct 29, 2019

SELL
$76.08 - $82.93 $18,639 - $20,317
-245 Reduced 1.98%
12,140 $975,000
Q2 2019

Jul 29, 2019

BUY
$69.84 - $81.59 $20,463 - $23,905
293 Added 2.42%
12,385 $1.04 Million
Q1 2019

Apr 29, 2019

BUY
$69.58 - $79.36 $126,426 - $144,197
1,817 Added 17.68%
12,092 $1.01 Million
Q4 2018

Jan 17, 2019

BUY
$65.24 - $75.71 $6,589 - $7,646
101 Added 0.99%
10,275 $785,000
Q3 2018

Nov 06, 2018

BUY
$57.69 - $67.84 $66,689 - $78,423
1,156 Added 12.82%
10,174 $722,000
Q2 2018

Aug 07, 2018

SELL
$50.83 - $59.72 $6,302 - $7,405
-124 Reduced 1.36%
9,018 $547,000
Q1 2018

May 04, 2018

BUY
$50.96 - $59.23 $79,803 - $92,754
1,566 Added 20.67%
9,142 $498,000
Q4 2017

Jan 12, 2018

BUY
$51.62 - $61.64 $391,073 - $466,984
7,576
7,576 $426,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $278B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Kcs Wealth Advisory Portfolio

Follow Kcs Wealth Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kcs Wealth Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Kcs Wealth Advisory with notifications on news.